Christopher M. Bobba

Christopher M. Bobba

Auto-generated profile, based on publicly available information

Christopher M. Bobba

Division of Cardiovascular Surgery, Department of Surgery, University of Florida College of Medicine, Gainesville, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2019 in JCI Insight
Verified
Journal Article
Open access
PDF file
JEJoshua A. Englert
Joshua A. Englert
CBChristopher Bobba
Christopher Bobba
RBRebecca M. Baron
Rebecca M. Baron
Sepsis-induced acute respiratory distress syndrome (ARDS) has high morbidity and mortality and arises after lung infection or infection at extrapulmonary sites. An aberrant host response to infection leads to disruption of the pulmonary alveolar-capillary barrier, resulting in lung injury characterized by hypoxemia, inflammation, and noncardiogenic pulmonary edema. Despite increased understanding of the molecular biology underlying sepsis-induced ARDS, there are no targeted pharmacologic therapies for this devastating condition. Here, we review the molecular underpinnings of sepsis-induced ARDS with a focus on relevant clinical and translational studies that point toward novel therapeutic strategies.

1 January 2014 in World Journal of Experimental Medicine
Verified
Journal Article
Open access
KNKevin Nelson
Kevin Nelson
CBChristopher Bobba
Christopher Bobba
SGSamir Ghadiali
Samir Ghadiali
DJDon Hayes Jr
Don Hayes Jr
SBSylvester M Black
Sylvester M Black
BWBryan A Whitson
Bryan A Whitson
Animal models of ex vivo lung perfusion as a platform for transplantation research

30 December 2016 in Langmuir
Verified
Journal Article
Closed access
GBG. D. Bothun
G. D. Bothun
NGN. Ganji
N. Ganji
IKI. A. Khan
I. A. Khan
AXA. Xi
A. Xi
CBC. Bobba
C. Bobba

17 June 2021 in JCI Insight
Verified
Journal Article
Open access
PDF file
HLHyunwook Lee
Hyunwook Lee
QFQinqin Fei
Qinqin Fei
ASAdam Streicher
Adam Streicher
WZWenjuan Zhang
Wenjuan Zhang
CIColleen Isabelle
Colleen Isabelle
JEJoshua A. Englert
Joshua A. Englert
The acute respiratory distress syndrome (ARDS) is a highly lethal condition that impairs lung function and causes respiratory failure. Mechanical ventilation (MV) maintains gas exchange in patients with ARDS but exposes lung cells to physical forces that exacerbate injury. Our data demonstrate that mTOR complex 1 (mTORC1) is a mechanosensor in lung epithelial cells and that activation of this pathway during MV impairs lung function. We found that mTORC1 is activated in lung epithelial cells following volutrauma and atelectrauma in mice and humanized in vitro models of the lung microenvironment. mTORC1 is also activated in lung tissue of mechanically ventilated patients with ARDS. Deletion of Tsc2 , a negative regulator of mTORC1, in epithelial cells impairs lung compliance during MV. Conversely, treatment with rapamycin at the time MV is initiated improves lung compliance without altering lung inflammation or barrier permeability. mTORC1 inhibition mitigates physiologic lung injury by preventing surfactant dysfunction during MV. Our data demonstrate that, in contrast to canonical mTORC1 activation under favorable growth conditions, activation of mTORC1 during MV exacerbates lung injury and inhibition of this pathway may be a novel therapeutic target to mitigate ventilator-induced lung injury during ARDS.

25 February 2015 in Journal of Visualized Experiments
Verified
Journal Article
Open access
PDF file
KNKevin Nelson
Kevin Nelson
CBChristopher Bobba
Christopher Bobba
EEEmre Eren
Emre Eren
TSTyler Spata
Tyler Spata
MTMalak Tadres
Malak Tadres
BWBryan A Whitson
Bryan A Whitson
The number of acceptable donor lungs available for lung transplantation is severely limited due to poor quality. Ex-Vivo Lung Perfusion (EVLP) has allowed lung transplantation in humans to become more readily available by enabling the ability to assess organs and expand the donor pool. As this technology expands and improves, the ability to potentially evaluate and improve the quality of substandard lungs prior to transplant is a critical need. In order to more rigorously evaluate these approaches, a reproducible animal model needs to be established that would allow for testing of improved techniques and management of the donated lungs as well as to the lung-transplant recipient. In addition, an EVLP animal model of associated pathologies, e.g., ventilation induced lung injury (VILI), would provide a novel method to evaluate treatments for these pathologies. Here, we describe the development of a rat EVLP lung program and refinements to this method that allow for a reproducible model for future expansion. We also describe the application of this EVLP system to model VILI in rat lungs. The goal is to provide the research community with key information and “pearls of wisdom”/techniques that arose from trial and error and are critical to establishing an EVLP system that is robust and reproducible.

3 June 2020 in Current Heart Failure Reports
Verified
Journal Article
Closed access
PDF file
MGMatthew L. Goodwin
Matthew L. Goodwin
CBChristopher M. Bobba
Christopher M. Bobba
NMNahush A. Mokadam
Nahush A. Mokadam
BWBryan A Whitson
Bryan A Whitson
MEMichael K. Essandoh
Michael K. Essandoh
AGAsvin M Ganapathi
Asvin M Ganapathi